Healthcare / Health Information ServicesTokyo
$2175.00
+16.00 (+0.74%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $3.0B · quality 68.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$65.3B
P/E
71.5x
↑EV/EBITDA
15.4x
↑ROE
6.6%
↑Gross Margin
63.0%
↑Debt/Equity
1.09
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+37.4%
FCF CAGR
+22.3%
FCF margin
8.1%
FCF / Net income
3.07x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $36.79B · net income $975.0M · FCF $2.99B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $36.79B | $36.79B | $29.30B | $20.53B | $14.19B |
| Net Income | $975.0M | $975.0M | $2.80B | $2.57B | $1.02B |
| EBITDA | $5.01B | $5.01B | $5.81B | $4.47B | $2.10B |
| EPS | 30.47 | 30.47 | 85.62 | 78.55 | 31.16 |
| Gross Margin | 63.0% | 63.0% | 64.6% | 66.2% | 68.5% |
| Operating Margin | 5.8% | 5.8% | 7.9% | 13.0% | 9.1% |
| Net Margin | 2.7% | 2.7% | 9.5% | 12.5% | 7.2% |
| Balance Sheet | |||||
| Debt/Equity | 1.09 | 1.09 | 0.75 | 0.09 | 0.16 |
| Current Ratio | 1.36 | 1.36 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.99B | $2.99B | $2.16B | $3.47B | $1.64B |
| Returns | |||||
| ROE | 6.6% | 6.6% | 13.8% | 14.6% | 6.7% |
| Valuation | |||||
| P/E | 71.45 | 71.45 | 44.79 | 52.58 | 121.47 |
| EV/EBITDA | 15.39 | 15.39 | 20.91 | 27.11 | 53.06 |
| P/B | 4.70 | 4.70 | 6.20 | 7.69 | 8.19 |
| Growth & Yield | |||||
| Revenue Growth | 25.5% | 25.5% | 42.7% | 44.7% | — |
| EPS Growth | -64.4% | -64.4% | 9.0% | 152.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
85.0%
EPS terminal req.
$193.00
Spread vs growth
-149.4%
5Y implied EPS CAGR
50.3%
EPS terminal req.
$233.52
Spread vs growth
-114.7%
10Y implied EPS CAGR
28.6%
EPS terminal req.
$376.09
Spread vs growth
-93.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.4%
Start / end P/E
36.0x → 71.4x
EPS bridge
85.62 → 30.47
Residual
-63.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.